Navigation Links
Omeros Announces Positive Clinical Results of OMS201 in Patients Undergoing Ureteroscopy
Date:12/29/2010

SEATTLE, Dec. 29, 2010 /PRNewswire-FirstCall/ -- Omeros Corporation (Nasdaq: OMER), a biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system, today announced results from the Phase 1/2 clinical trial of OMS201, the Company's urological PharmacoSurgery™ product candidate. OMS201 is a proprietary combination of an anti-inflammatory agent and a smooth muscle relaxant, each with well-known safety and pharmacologic profiles.

Based on the successfully completed Phase 1 trial of a lower concentration of OMS201, this Phase 1/2 study was designed to evaluate the safety and systemic absorption of two sequentially higher concentrations of OMS201 added to standard irrigation solution and delivered to patients undergoing ureteroscopy for removal of ureteral or renal stones. This multicenter, double-blind, placebo-controlled study also explored potential efficacy endpoints but was not powered to assess efficacy. Based on an interim analysis of the pharmacokinetic data, which demonstrated low maximal systemic absorption of the active ingredients, trial enrollment was truncated from the originally planned 36 patients to a total of 24 patients.

OMS201 was safe and well tolerated in this study. The incidence of adverse events was similar in the two OMS201-concentration arms and the group receiving vehicle. No adverse events were considered treatment-related by investigators. There were no deaths or discontinuations for adverse events. Only one serious adverse event was reported, which occurred in a vehicle-treated patient.

"We are pleased with the results of this trial, which demonstrated an absence of side-effects even at a concentration of OMS201 ten times higher than that examined in our earlier Phase 1 clinical study," said Gregory A. Demopulos, M.D., chairman and
'/>"/>

SOURCE Omeros Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Omeros to Host Conference Call Monday, October 25 at 4:00 p.m. ET To Provide Corporate Update
2. Omeros to Present at the BioCentury NewsMakers Conference
3. Omeros Enrolls First Patient in Phase 2b Clinical Trial Evaluating OMS302 in Patients Undergoing Cataract Surgery
4. Omeros Successfully Unlocks Orphan GPCRs
5. Omeros Selects Clinical Candidate for MASP-2 Program With Potential Applicability to Multiple Inflammatory Disorders
6. Omeros Reports Additional Phase 2 Data Showing Multiple Clinical Benefits In Patients Undergoing Meniscectomy Surgery
7. Omeros Announces National Institute on Drug Abuses Support for Phase 2 Clinical Study in Addiction Program
8. Daniel K. Spiegelman Elected to Board of Directors of Omeros
9. Omeros Corporation to Host Third Quarter 2009 Financial Results Conference Call on November 19
10. Omeros Prices Initial Public Offering of Common Stock at $10.00 Per Share
11. Omeros Receives $3.1 Million Milestone Payment from The Stanley Medical Research Institute for Schizophrenia Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... Calif. , Dec. 22, 2014 Apnea ... expanded corporate offices in Aliso Viejo ... that due to the tremendous growth and worldwide expansion, ... Sales of patented SnoreRx, the anti snore cure have ... He said, "We are now in 23 countries ...
(Date:12/22/2014)... , Dec. 22, 2014   TRU-D SmartUVC ... UV disinfection robot, announced today that the General Services ... through November 2019.   This newly formed ... all levels of government purchasers, including Department of Veteran ... as Homeland Security contacts purchasing solutions for the Ebola ...
(Date:12/22/2014)... , Dec. 22, 2014  ConvaTec, a privately-held medical ... has been appointed Interim Chief Executive Officer of the ... succeeds Ken Berger .  "The Board of Directors ... leading ConvaTec over the past three years," said ... Directors.  "We are confident that the company is well ...
Breaking Medicine Technology:TRU-D SmartUVC LLC Awarded General Services Administration Contract to Expand Government Customer Base 2ConvaTec Names Paul Moraviec Interim CEO Effective December 22, 2014 2
... Pharmasset, Inc. (Nasdaq: VRUS ) announces that ... held May 2 to 4, 2011 at the InterContinental Hotel, ... Healthcare Conference being held May 10 to 12, 2011, at ... President and Chief Executive Officer, will provide an overview of ...
... April 28, 2011 Biodesix announces the enrollment of ... Addario Lung Cancer Medical Institute (ALCMI, pronounced as "Alchemy"). ... is recruiting a minimum of 250 subjects over two ... United States. The study collects biospecimens and data from ...
Cached Medicine Technology:Pharmasset to Present at Two Upcoming Investor Conferences 2Pharmasset to Present at Two Upcoming Investor Conferences 3Biodesix Supports Unique Lung Cancer Research Initiative 2Biodesix Supports Unique Lung Cancer Research Initiative 3
(Date:12/26/2014)... 2014 Parker & Sons, Inc. ... in heating, cooling and plumbing contractor services throughout ... services in 2014 with regard to air-conditioning systems. ... is known for its incredibly hot summers. Working ... intricacies and details of a wide variety of ...
(Date:12/25/2014)... 2014 The click strand ... strength and durability. Today, the business announces a ... valid until Jan. 30, 2015. , Click strand ... hardwood. BambooFlooringChina.com is a well-known brand in the ... to find a reliable bamboo flooring supplier. , ...
(Date:12/25/2014)... 2014 Product liability lawsuits filed in ... ( http://www.consumerinjurylawyers.com/DePuy/ ) continue to move forward in federal ... issued in the U.S. District Court, Northern District of ... open conference on January 7, 2015, at the Paul ... West Palm Beach, Florida. The Conference is scheduled to ...
(Date:12/25/2014)... Recently, Dylan Queen, a famous online company supplying ... of discounted prom dresses, most of which are priced ... the company, the promotion is valid until Jan. 22, ... the UK market. , The prom dresses in this ... styles: A-line strapless, empire strapless chiffon, one shoulder, floor-length, ...
(Date:12/25/2014)... sells many bamboo products and the business is famous ... announces big discounts on its bamboo mats , which ... the world’s leader in bamboo flooring. According to the ... 2015. , The bamboo mats are made from well-treated ... the bamboo strips for the mats are boiled and ...
Breaking Medicine News(10 mins):Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 2Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 3Health News:BambooFlooringChina.com: click strand woven bamboo flooring promotion valid until Jan. 30, 2015. 2Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 3Health News:Dylan Queen: Cheap Prom Dresses for the UK Market 2Health News:Various Styles of Bamboo Mats in Many Colors from BambooFlooringChina.com 2
... screening that combines an adjusted blood test with other factors ... and family history, can help up to one-quarter of men ... Israel Deaconess Medical Center-led research team says. Writing in ... the team led by Martin G. Sanda, MD, Director of ...
... in French . , Researchers have revealed ... the integrity of our genetic code, and when it is ... in the development of cancer. The University of Montreal scientists ... by using cutting edge microscopy techniques to visualize telomerase molecules ...
... By Amanda Gardner HealthDay Reporter , WEDNESDAY, ... they are heartened by the results of two new ... women with two different types of advanced tumors. ... in women with hormone receptor-positive breast cancer but is ...
... they are burned out and dissatisfied with their jobs, reported ... for Health Outcomes and Policy Research in a study of ... 60 percent of nurses reported symptoms of burnout according to ... in Health Care , which collected data from nurses in ...
... mycoestrogen zearalenone (ZEN), a naturally occurring toxin that widely ... breast cancer. That is the warning from breast health ... publication in the January issue of IJCP , ... "No clinical trials have been published on the use ...
... health care system in the United States faces numerous challenges: ... how to ensure more equitable use of medical services and, ... for that care. The 10th Biennial Regenstrief Institute ... Medical Care tackles key conceptual questions, reviews effective ...
Cached Medicine News:Health News:PSA testing, combined with other relevant patient data can reduce unnecessary prostate biopsies 2Health News:PSA testing, combined with other relevant patient data can reduce unnecessary prostate biopsies 3Health News:Scientists capture single cancer molecules at work 2Health News:Two New Drug Combos May Fight Advanced Breast Cancers 2Health News:Two New Drug Combos May Fight Advanced Breast Cancers 3Health News:To keep nurses, improve their work environments 2Health News:Women advised to avoid ZEN bust-enhancing supplements because of possible cancer risk 2Health News:Journal supplement presents strategies for introducing health care delivery innovation 2
Traditional design utility pliers have adjustable jaws. Good all purpose plier for handling Steinmann Pins, K-Wires, screws and rods. 10mm jaw tip....
The Wire Cutters are designed to cut Kirschner wires up to 2.5 mm diameter easily and smoothly. They are particularly useful for external fixation applications. The Wire Cutters shear fixation wires ...
Curved osteotome for bone removing....
... Spectral system is a combination Spectral Optical ... (SLO) system that provides suberb, high-quality images ... With the advancements of spectral technology, OTI's ... to 27,000 A-Scans per second and provide ...
Medicine Products: